1. Home
  2. ISPC vs PTIX Comparison

ISPC vs PTIX Comparison

Compare ISPC & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISPC
  • PTIX
  • Stock Information
  • Founded
  • ISPC 2009
  • PTIX 1994
  • Country
  • ISPC United States
  • PTIX United States
  • Employees
  • ISPC N/A
  • PTIX N/A
  • Industry
  • ISPC Precision Instruments
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ISPC Health Care
  • PTIX Health Care
  • Exchange
  • ISPC Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • ISPC 2.0M
  • PTIX 2.0M
  • IPO Year
  • ISPC 2021
  • PTIX 2016
  • Fundamental
  • Price
  • ISPC $1.74
  • PTIX $0.27
  • Analyst Decision
  • ISPC
  • PTIX
  • Analyst Count
  • ISPC 0
  • PTIX 0
  • Target Price
  • ISPC N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • ISPC 120.7K
  • PTIX 599.7K
  • Earning Date
  • ISPC 03-12-2025
  • PTIX 03-31-2025
  • Dividend Yield
  • ISPC N/A
  • PTIX N/A
  • EPS Growth
  • ISPC N/A
  • PTIX N/A
  • EPS
  • ISPC N/A
  • PTIX N/A
  • Revenue
  • ISPC $10,390,702.00
  • PTIX N/A
  • Revenue This Year
  • ISPC $13.82
  • PTIX N/A
  • Revenue Next Year
  • ISPC $11.76
  • PTIX N/A
  • P/E Ratio
  • ISPC N/A
  • PTIX N/A
  • Revenue Growth
  • ISPC 0.74
  • PTIX N/A
  • 52 Week Low
  • ISPC $1.73
  • PTIX $0.25
  • 52 Week High
  • ISPC $11.80
  • PTIX $1.87
  • Technical
  • Relative Strength Index (RSI)
  • ISPC 32.34
  • PTIX 34.94
  • Support Level
  • ISPC $1.76
  • PTIX $0.25
  • Resistance Level
  • ISPC $1.99
  • PTIX $0.30
  • Average True Range (ATR)
  • ISPC 0.16
  • PTIX 0.03
  • MACD
  • ISPC 0.02
  • PTIX 0.00
  • Stochastic Oscillator
  • ISPC 2.13
  • PTIX 10.43

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: